Skip to main content
The words approved in red capitalized letters.

FDA clears Cipla’s generic Brovana

Brovana had a market value of  approximately $438 million for the 12-month period ending April 2021, according to IQVIA.
Levy

The Food and Drug Administration has given Cipla the nod for arformoterol tartrate inhalation solution 15 mcg / 2 mL.

The medication is the generic of Sunovion Pharmaceuticals’ Brovana.

Brovana is indicated for long-term, twice daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.

Brovana had a market value of  approximately $438 million for the 12-month period ending April 2021, according to IQVIA.

The product is available for shipping immediately.

X
This ad will auto-close in 10 seconds